Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Authors
Keywords
-
Journal
Clinical and Translational Gastroenterology
Volume 8, Issue 10, Pages e125
Publisher
Springer Nature
Online
2017-10-26
DOI
10.1038/ctg.2017.51
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic Hepatitis B Virus Infection
- (2016) Man-Fung Yuen et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Parallel 18: Hepatobiliary Neoplasia I
- (2015) HEPATOLOGY
- Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
- (2015) Takao Watanabe et al. Hepatology International
- Hepatitis B Surface Antigen Seroclearance: Relationship to Hepatitis B e-Antigen Seroclearance and Hepatitis B e-Antigen-Negative Hepatitis
- (2014) James Fung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
- (2014) W.-K. Seto et al. CLINICAL MICROBIOLOGY AND INFECTION
- Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
- (2014) Pauline Arends et al. GUT
- Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
- (2013) Danny Ka-Ho Wong et al. Clinical Gastroenterology and Hepatology
- HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
- (2013) Gi-Ae Kim et al. GUT
- Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy
- (2013) Wai-Kay Seto et al. HEPATOLOGY
- Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment
- (2013) Wai-Kay Seto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
- (2012) Tai–Chung Tseng et al. GASTROENTEROLOGY
- Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
- (2012) Tai-Chung Tseng et al. HEPATOLOGY
- A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance
- (2012) Wai-Kay Seto et al. HEPATOLOGY
- Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety
- (2011) Man-Fung Yuen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
- (2010) Tetsuya Hosaka et al. LIVER INTERNATIONAL
- HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
- (2008) Man–Fung Yuen et al. GASTROENTEROLOGY
- Hepatitis B Core-Related Antigen Assay Is Useful for Monitoring the Antiviral Effects of Nucleoside Analogue Therapy
- (2008) Eiji Tanaka et al. INTERVIROLOGY
- Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients
- (2008) Fumitaka Suzuki et al. JOURNAL OF MEDICAL VIROLOGY
- Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach
- (2007) Jean–Michel Pawlotsky et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search